Published: Jan. 1, 2024
Language: Английский
Published: Jan. 1, 2024
Language: Английский
Tetrahedron, Journal Year: 2025, Volume and Issue: unknown, P. 134609 - 134609
Published: March 1, 2025
Language: Английский
Citations
0Organic Letters, Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 24, 2025
Herein a novel and robust methodology to spiroimidazolidinones has been developed under mild reaction. The reaction of (Z)-2-azido-3-phenylacrylic acids 1, aldehydes 2, amines 3, isocyanides 4, 6 produced regioselectively in 71–88% yields via sequential Ugi 4CR/Pd(0) catalyzed azide-isocyanide coupling/cyclization/rearrangement/hydroxylation Furthermore, the easily accessible starting materials, high bond-forming efficiency, broad substituent tolerance make this strategy useful synthetic medicinal chemistry.
Language: Английский
Citations
0Chinese Journal of Chemistry, Journal Year: 2024, Volume and Issue: 42(18), P. 2140 - 2146
Published: May 7, 2024
Comprehensive Summary Herein, we reported a precise de novo synthesis of chiral 3,4‐dihydroquinazoline frameworks via one‐pot anionic stereogenic‐at‐cobalt(III) complex‐catalyzed enantioselective Ugi‐azide/Pd‐catalyzed cyclization sequence. This powerful protocol involves 5 components and 2 catalytic systems, delivering 3,4‐dihydroquinazolines with excellent enantioselectivities (up to 94% ee). The preliminary antifungal experiments suggest that both Ugi‐adducts have great potential in inhibiting plant pathogens such as Trichoderma viride Fusarium graminearum .
Language: Английский
Citations
2Published: Jan. 1, 2024
Language: Английский
Citations
0